期刊文献+

HPLC法测定注射用兰索拉唑的有关物质及主药含量 被引量:4

Determination of Lansoprazole and Related Substances in Lansoprazole Injection by HPLC
下载PDF
导出
摘要 目的:建立注射用兰索拉唑含量及有关物质的反相高效液相色谱(RP-HPLC)测定法。方法:采用Agilent EclipseXDB-C_8色谱柱,三乙胺水溶液[取三乙胺10 ml,加水350 ml,以磷酸(1→10)调节pH至5.5[-甲醇(36:65)为流动相,流速:1.0 ml·min^(-1),检测波长284 nm。结果:兰索拉唑与杂质A、B、C、D、E的分离度均符合要求,系统适用性良好,兰索拉唑在0.303~2.725μg范围内线性关系良好,方法平均回收率为99.8%(RSD=0.64%)。结论:该法简便、准确,可用于注射用兰索拉唑的主药含量及有关物质测定。 To establish an HPLC method for determination of lansoprazole and related substances in Lansoprazole injection. Method:An Agilent Eclipse XDB-C_8 column was used with mobile phase of water solution of triethylamine(measure triethylamine 10ml,add water 350ml,then regelated pH to 5.5 with phosphoric acid solution)-methanol(36:65).The flow rate was 1.0ml·min-land the detection wavelength was 284nm.Result:There was a good resolution between the lansoprazole and all the impurities (A,B,C,D,E),and the system suitability was fine.It had a good linearity over the concertration range of 0.303-2.725μg.The average recovery was 99.8%with RSD of 0.64%.Conclusion:The method is accurate and convenient,can be used for determination of lansoprazole and related substances in Lansoprazole injection.
出处 《中国药师》 CAS 2013年第7期1079-1081,共3页 China Pharmacist
关键词 兰索拉唑 高效液相色谱法 含量测定 有关物质 Lansoprazole HPLC Determination Related substances
  • 相关文献

参考文献7

二级参考文献20

  • 1陈东燕,孙艳荪,乔珊,吴子刚.CYP2C19基因多态性对幽门螺杆菌感染酸相关性疾病治愈率的影响[J].实用医学杂志,2006,22(19):2324-2326. 被引量:7
  • 2Yu-rongHU Hai-lingQIAO Quan-chengKAN.Pharmacokinetics of lansoprazole in Chinese healthy subjects in relation to CYP2C19 genotypes[J].Acta Pharmacologica Sinica,2004,25(8):986-990. 被引量:12
  • 3李见春,胡齐胜,高署,蒋志文.兰索拉唑肠溶片人体生物等效性研究[J].中国临床药理学与治疗学,2006,11(5):558-561. 被引量:7
  • 4曾晓晖,石磊,罗新根,徐新军,龚丽娴,黄雪峰.反相高效液相色谱法测定人血浆中兰索拉唑的浓度[J].中国药师,2006,9(9):823-825. 被引量:15
  • 5Saito M,Yasui-Funukori N,Uno T,et al.Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes[J].Br J Pharmacol,2005,59 (3):302-309.
  • 6Michaud V,Turgeon J.Assessment of Competitive and MechanismBased Inhibition by Clarithromycin:Use of Domperidone as a CYP3A Probe-Drug Substrate and Various Enzymatic Sources Including a New Cell-Based Assay with Freshly Isolated Human Hepatocytes[J].Drug Metab Lett,2010,4(2):69-76.
  • 7Song M,Gao X,Hang T,et al.Simultaneous determination of lansoprazole and its metabolites 5'-hydroxy lansoprazolc and hmsoprazole sulphone in human plasma by LC-MS/MS:application to a pharmacokinetic study in healthy volunteers[J].J Pharm Biomed Anal,2008,48(4):1181-1186.
  • 8KAROL M D,GRANNEMAN G R,ALEXANDER K.Determination of lansoprazole and five metabolites in plasma by high-performance liquid chromatography[J].J Chromatography B,668(1995):182-186.
  • 9中国药典 2000 年版.二部[S].2000.
  • 10ALBIN K,FRANC V.Preformulation investigation of the novel proton pump inhibitor lansoprazole[J].Drug Development and Industrial Pharmacy,26(7):781-783(2000).

共引文献63

同被引文献43

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部